Clinical Trial Update: Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and preliminary activity of combining IMRT-based radiation therapy with everolimus (RAD001) and cisplatin in patients with h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Everolimus (everolimus)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED